0001209191-19-018095.txt : 20190308 0001209191-19-018095.hdr.sgml : 20190308 20190308162032 ACCESSION NUMBER: 0001209191-19-018095 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190306 FILED AS OF DATE: 20190308 DATE AS OF CHANGE: 20190308 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Arkowitz David CENTRAL INDEX KEY: 0001296999 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37695 FILM NUMBER: 19669351 MAIL ADDRESS: STREET 1: C/O FLEXION THERAPEUTICS, INC. STREET 2: 10 MALL ROAD, SUITE 301 CITY: BURLINGTON STATE: MA ZIP: 01803 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PROTEOSTASIS THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001445283 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE BUSINESS ADDRESS: STREET 1: 80 GUEST STREET STREET 2: 5TH FLOOR CITY: BOSTON STATE: MA ZIP: 02135 BUSINESS PHONE: 617-225-0096 MAIL ADDRESS: STREET 1: 80 GUEST STREET STREET 2: 5TH FLOOR CITY: BOSTON STATE: MA ZIP: 02135 FORMER COMPANY: FORMER CONFORMED NAME: PROTEOSTASIS THERAPEUTICS INC DATE OF NAME CHANGE: 20080916 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-03-06 0 0001445283 PROTEOSTASIS THERAPEUTICS, INC. PTI 0001296999 Arkowitz David C/O PROTEOSTASIS THERAPEUTICS, INC. 80 GUEST STREET, SUITE 500 BOSTON MA 02135 1 0 0 0 Stock Option (Right to Buy) 4.07 2019-03-06 4 A 0 30600 0.00 A 2029-03-06 Common Stock 30600 30600 D These securities shall vest and become exercisable in equal quarterly installments starting on June 6, 2019 until the option is fully vested and exercisable on March 6, 2020, subject to continued service. Janet L. Smart, as Attorney-in-Fact 2019-03-08